|
Research Progress of Qiweibaizhu Powder in Treating Digestive System Diseases |
|
View Full Text View/Add Comment Download reader |
DOI:10.4103/wjtcm.wjtcm_51_21 |
KeyWord:Antibiotic‑associated diarrhea, intestinal microbiota, mesenteric lymphadenitis, spleen deficiency, viral diarrhea |
Author | Institution |
Shi‑Qi Liua |
a.College of Basic Medical Sciences, Heilongjiang University of Chinese Medicine, Harbin, China |
Ji Lia |
a.College of Basic Medical Sciences, Heilongjiang University of Chinese Medicine, Harbin, China |
|
Hits: 477 |
Download times: 621 |
Abstract: |
Diarrhea is a common clinical problem that can lead to health complications, including death. It is the second-most common cause of death in
children. The World Health Organization introduced a program to encourage the development and use of traditional herbal medicines in the
treatment of diarrhea. Qiweibaizhu Powder (QWBZP) is a well-known pediatric prescription in China that is commonly used to treat digestive
system diseases, such as diarrhea, which is also a type of syndrome in traditional Chinese medicine. Many studies have examined the clinical
effects and mechanisms of QWBZP, and innovative and improved formulations have been developed. Recentstudies on the effects of QWBZP
on diarrhea caused by human rotavirus, antibiotic‑associated diarrhea, and mesenteric lymphadenitis in experimental models and clinical
trials with diarrhea patients have been reviewed. We conducted a literature search of several databases, including PubMed, China National
Knowledge Infrastructure, Chongqing VIP Information Co., Ltd., and Wanfang. A short background of the QWBZP is also provided. The
collective findings highlight the curative effects of QWBZP on diarrhea caused by viral infection, antibiotic use, and mesenteric lymphadenitis.
Furthermore, QWBZP can regulate the balance of the gastrointestinal microbiota and protect and repair the intestinal mucosal barrier. This
review will provide a reference for further studies on QWBZP. |
Close |
|
|
|